The next generation of healthcare

Created as a spin-off of the Italian National Research Council, Echolight is at the forefront of medical innovation, introducing new cutting-edge solutions to contribute to human wellbeing. We have been awarded all the standard certificates: UNI CEI EN ISO 13485: 2016, Quality Management System UNI EN ISO 9001: 2015, CE mark, FDA approval and other major certificates worldwide for our innovative solutions.

The next generation of healthcare

Created as a spin-off of the Italian National Research Council, Echolight is at the forefront of medical innovation, introducing new cutting-edge solutions to contribute to human wellbeing. We have been awarded all the standard certificates: UNI CEI EN ISO 13485: 2016, Quality Management System UNI EN ISO 9001: 2015, CE mark, FDA approval and other major certificates worldwide for our innovative solutions.

2010

Start

Echolight srl was officially incorporated by the founding team with a revolutionary idea: developing the first radiation-free device for early diagnosis of osteoporosis at the lumbar vertebrae and the femoral neck.

Patent

Viene ufficialmente depositato il primo brevetto della tecnologia R.E.M.S.: innovativo approccio ecografico per la caratterizzazione della micro-architettura ossea.

2011

Life Science Capital

Life Science Capital S.p.a., an italian investment company in the medical device sector, invests in Echolight to support and speed up the research and development activities of the company.

EchoS

The first version of Echos is finalized: the only radiation free device for bone densitometry at the lumbar vertebrae and the femoral neck. A decisive step towards a new era in the early diagnosis of osteoporosis and bone health assessment.

2012

2013

Clinical trials

In collaboration with the National Council of Research the first multi-center study for the clinical validation of R.E.M.S. technology in the most important reference centers for the diagnosis of osteoporosis is launched.

Certifications

Echolight ottiene tutte le certificazioni standard: UNI CEI EN ISO 13485: 2012, ISO 13485: 2003, UNI EN ISO 9001: 2008 Sistema di gestione della qualità e il marchio CE per Echos, EchoStation ed EchoStudio di KIWA CERMET.

2014

2015

Premiere

Echolight introduces to the international medical community the latest release of Echos at the World Congress of Osteoporosis.

Round A

Panakès and Invitalia Ventures have co-led an investment round in Echolight, in order to support the clinical validation of the innovative technology and the worldwide launch of the product.

2016

Advisory Board

Echolight established the new international scientific advisory board with the most important medical personalities in the diagnosis of osteoporosis.

2017

Market Launch

Echolight at the International Trade Fair MEDICA launched Echos after extensive research and development activities carried out over the last eight years.

FDA Clereance

Echolight S.p.A. has received 510(k) clearance from the Food and Drug Administration (FDA) to market its range of products in the U.S.A.

2018

Multicenter Study

Milestone pubblication on Osteoporosis International about R.E.M.S. Multicenter Clinical Trial: “Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck.

Consensus Paper

Echolight obtained a Consensus Paper from ESCEO (European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, on R.E.M.S. technology.

2019

Echolight around the globe

Echolight in less than three years has a sales network of 40 distributors and several hundred satisfied customers all over the world.

2020

Echolight USA

Echolight announces the opening of a new corporate headquarters in the United States located in Seattle.

R.E.M.S. in the guidelines

R.E.M.S. technology recommended in the guidelines for fragility fractures risk assessment.

2021

Echolight around the globe

Echolight was established in Italy with head office in Lecce. In 2020, Echolight opened its offices also in the United States (Seattle) and in less than three years, it already has a sales network with more than 40 distributors and several hundreds of satisfied customers across the world who have adopted the innovative R.E.M.S. technology for assessing the bone condition of their patients.

Become distributor

    Contact Us

    More info or book a demo.



    Position*

    *Required fields



    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Echolight S.p.a.

    Viale Cipro, 6
    73100 Lecce – Italy
    +39 0832 159 26 07

    US Headquarters
    509 Madison Ave RM 1510
    New York, New York 10022, USA
    +1-833-263-7367
    +1 425 658 0601

    Copyright © 2021 - Echolight S.p.a